Ascendia Pharmaceuticals is a specialty pharmaceutical CDMO that provides custom sterile- and non-sterile-enabling formulations and manufacturing, along with analytical methods for new chemical entities, complex dosage forms, and 505(B)(2) product development.
CREATING FORMULATIONS FOR POORLY WATER SOLUBLE MOLECULES
Ascendia makes the Insoluble Soluble by delivering sophisticated formulations to enhance bioavailability and solubility using its four proprietary nanotechnologies – NanoSol®, EmulSol®, AmorSol®, and LipidSol®. The company built its foundation of success on its customer-centric culture that exudes its BEST philosophy (Brilliant technology, Excellent service, Superior quality, and Trust).
Our practical, customized formulation solutions enable rapid advancement of compounds from discovery to clinical testing. We provide trial formulations suitable for initial animal studies and toxicology studies. We conduct pre-formulation testing, formulation approach comparisons, dosage form design and formulation optimization.
MANUFACTURE OF cGMP CLINICAL TRIAL MATERIALS
Following formulation selection and optimization, Ascendia can transition a development program quickly to cGMP manufacture of clinical materials. Ascendia’s manufacturing capabilities include dosage forms for oral, topical or parenteral administration. Ascendia offers its manufacturing services to pharmaceutical and biopharmaceutical companies who seek a CDMO partner for their formulation as it transfers from a pre-clinical phase to clinical development.
MORE THAN A CDMO FOR BIOLOGICS
As a specialty CDMO, Ascendia has invested heavily in drug delivery nanotechnologies that aid in biologics, as well as other large and small molecule formulations. The versatility of EmulSol, NanoSol, AmorSol, and LipidSol helps Ascendia successfully address almost all new compounds with different challenging properties, including biologicals, to help make the Impossible Possible.